Rchr
J-GLOBAL ID:201801007645978890   Update date: Apr. 05, 2024

Sato Hiroki

サトウ ヒロキ | Sato Hiroki
Affiliation and department:
Job title: Lecturer
Research field  (1): Tumor biology
Research theme for competitive and other funds  (3):
  • 2021 - 2025 細胞増殖因子プロセッシングのエンドクリン制御を起点とするがん転移ニッチ形成の研究
  • 2018 - 2021 特殊環状ペプチドを診断ツールとする低侵襲的な腫瘍特性解析法の開発
  • 2016 - 2018 特殊環状ペプチドをイメージングツールとするがん微小転移および薬剤耐性に関する研究
Papers (33):
  • Ryu Imamura, Hiroki Sato, Dominic Chih-Cheng Voon, Takayoshi Shirasaki, Masao Honda, Makoto Kurachi, Katsuya Sakai, Kunio Matsumoto. Met receptor is essential for MAVS-mediated antiviral innate immunity in epithelial cells independent of its kinase activity. Proceedings of the National Academy of Sciences of the United States of America. 2023. 120. 40. e2307318120
  • Naoya Kawakami, Hiroki Sato, Naohiro Terasaka, Kunio Matsumoto, Hiroaki Suga. MET-Activating Ubiquitin Multimers. Angewandte Chemie International Edition. 2023
  • Shota Warashina, Hiroki Sato, Maki Zouda, Maiko Takahashi, Yasuhiro Wada, Toby Passioura, Hiroaki Suga, Yasuyoshi Watanabe, Kunio Matsumoto, Hidefumi Mukai. Two-Chain Mature Hepatocyte Growth Factor-Specific Positron Emission Tomography Imaging in Tumors Using 64Cu-Labeled HiP-8, a Nonstandard Macrocyclic Peptide Probe. Molecular pharmaceutics. 2023. 20. 4. 2029-2038
  • Yohei Takumi, Sachiko Arai, Chiaki Suzuki, Koji Fukuda, Akihiro Nishiyama, Shinji Takeuchi, Hiroki Sato, Kunio Matsumoto, Kenji Sugio, Seiji Yano. MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements. Cancer medicine. 2022
  • Katsuya Sakai, Nozomi Sugano-Nakamura, Emiko Mihara, Nichole Marcela Rojas-Chaverra, Sayako Watanabe, Hiroki Sato, Ryu Imamura, Dominic Chih-Cheng Voon, Itsuki Sakai, Chihiro Yamasaki, et al. Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions. Nature Biomedical Engineering. 2022. 7. 2. 164-176
more...
MISC (4):
  • Hiroki Sato, Katsuya Sakai, Ryu Imamura, Kunio Matsumoto. HGF conversion in bronchial epithelial cells triggers pre-metastatic niche formation in the lung. CANCER SCIENCE. 2022. 113. 1142-1142
  • Hiroki Sato, Ryu Imamura, Katsuya Sakai, Hiroko Oshima, Masanobu Oshima, Kazuhiro Murakami, Yumi Terakado, Yukinari Kato, Seiji Yano, Kunio Matsumoto. Roles of Mature HGF in Gastric Tissue Regeneration and Tumorigenesis. CANCER SCIENCE. 2021. 112. 422-422
  • 鴨志田剛, 鴨志田剛, 小川崇, 小柳潤, 佐藤拓輝, 古宮栄利子, 東昌市, 宮崎香, 斧康雄, 辻勉. 細胞外マトリックスタンパク質ラミニン-332による単球の腫瘍関連マクロファージへの分化調節. Pharmaco-Hematologyシンポジウム講演要旨集. 2013. 14th
  • 佐藤拓輝, 小柳潤, 藤田幸, 東昌市, 宮崎香. がん浸潤マーカー「ラミニンγ2鎖」と血管内皮細胞の相互作用. 生化学. 2010
Lectures and oral presentations  (4):
  • Roles of Mature HGF in Gastric Tissue Regeneration and Tumorigenesis
    (2020)
  • Specific Detection of Active HGF for Diagnosis Reflecting Activation Status of HGF-MET Signaling by Macrocyclic Peptide
    (2019)
  • HGF produced by smooth muscle cells promotes lung metastasis as a metastatic niche component
    (The 77th Annual Meeting of the Japanese Cancer Association 2018)
  • Lung metastatic niche formation by activated HGF in bronchial epithelium
    (The 27th Annual Meeting The Japanese Association for Metastasis Research 2018)
Work history (4):
  • 2024/04 - 現在 Yokohama City University School of Science Lecturer
  • 2018/04 - 2024/03 Kanazawa University Cancer Research Institute assistant professor
  • 2016/04 - 2018/03 Kanazawa University Cancer Research Institute assistant professor
  • 2014/04 - 2016/03 Asahi Glass Co., Ltd Kumagai Fellow Laboratory
Awards (3):
  • 2021/09 - Japan Cancer Association JCA Young Researcher Poster Award
  • 2015/10 - World Conference on Regenerative Medicine, Poster Award
  • 2012/07 - International Biennial Congress of the Metastasis Research Society Travel award
Association Membership(s) (2):
THE JAPANESE ASSOCIATION FOR METASTASIS RESEARCH ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page